Asset Management and Custody Banks

Hamilton Lane 

Hamilton Lane Q4 EPS hits $1.49, Dividend Raised 11% to Annual $2.40 Target

Hamilton Lane to Release FY2026 Q4 Earnings on May 21 Pre-Market EST, Forecast Revenue USD 203.25 M, EPS USD 1.43

JPMorgan Raises Hamilton Lane's Stock Rating to 'Overweight'

Artisan Partners Increased Holdings in Hamilton Lane to $42.88 million

Hamilton Lane Inc. Co-Chairman Acquires Company's Common Stock

Hamilton Lane Leads $500 Million Investment in VFN Holdings

Hamilton Lane Announces $50 Million Buyback Program

Hamilton Lane released FY2026 Q3 earnings on February 3, Pre-Market EST, with actual revenue of USD 198.59 M (forecast USD 195.52 M) and actual EPS of USD 1.3692 (forecast USD 1.27)

Hamilton Lane released FY2026 9 Months earnings on February 3 Pre-Market (EST), actual revenue USD 565.43 M, actual EPS USD 4.3425

Hamilton Lane Inc. Reports Q3 2026 Earnings, Revenue Exceeds Expectations

Hamilton Lane to release FY2026 Q3 earnings on February 3, Pre-Market EST, with forecast revenue of USD 195.52 M and EPS of USD 1.27

Hamilton Lane CEO Acquires Company's Common Stock

Hamilton Lane Inc Reports Strong Growth and Positive Outlook in Earnings Call

Hamilton Lane released FY2026 Semi-Annual earnings on November 4, Pre-Market (EST), actual revenue USD 366.84 M, actual EPS USD 2.9799

Hamilton Lane released FY2026 Q2 earnings on November 4 Pre-Market EST, actual revenue USD 190.88 M (forecast USD 169.44 M), actual EPS USD 1.6923 (forecast USD 1.12)

Hamilton Lane Inc. reports 29% YoY growth in Q2 net income

Hamilton Lane to Release FY2026 Q2 Earnings on November 4, Pre-Market EST; Forecast Revenue USD 169.44 M, EPS USD 1.09

Hamilton Lane Inc. Partners with KAIO to Tokenize SCOPE on Sei Network

Hamilton Lane Inc amends $75 million Term Loan Agreement

BMO Capital Markets Rates Hamilton Lane as Outperform

Optimi Health

HCW Biologics

Silexion Therapeutics

Vida Global

GCL Global

BiomX

MetaVia

Micware

MicroAlgo

Earning Release Date

财报预告

FY2026 Q4 Earning Release Today 2026.05.21 (EST) Pre-Market

HLNE

Hamilton Lane INC (HLNE) reported a Q4 profit of $50.49 million, or $1.57 per share, down from $66.17 million, or $1.23 per share, last year. Adjusted earnings were $81.04 million, or $1.49 per share. Revenue declined by 2.2% to $193.57 million from $197.97 million in the previous year.

nasdaq

Nasdaq

Hamilton Lane INC Q4 Sales Decline

Hamilton Lane Incorporated (Nasdaq: HLNE) reported its financial results for Q4 and fiscal year 2026, ending March 31, 2026, during a presentation on May 21, 2026, in Conshohocken, Pennsylvania.

Unusual Whales

HAMILTON LANE INCORPORATED REPORTS FOURTH QUARTER AND FISCAL YEAR 2026 RESULTS

Hamilton Lane (HLNE) will announce its Q1 earnings this Thursday. Last quarter, it reported $198.6 million in revenue, an 18% year-on-year increase. This quarter, revenue is expected to grow by 1.2%. Analysts have maintained their estimates, indicating stability. Hamilton Lane's stock has declined 22.5% recently, with an average price target of $135.57 against a current price of $82.76.

Stock Story

Franklin Resources

Voya Financial

Amazon

Paypal

Meta Platforms

VOYA FINANCIAL INC 5.35% DEP SHS REP 1/40TH NON CUM SER B

Hamilton Lane (HLNE) Q1 Earnings Report Preview: What To Look For

Hamilton Lane (HLNE) has launched new interval funds, attracting over $350 million in commitments. Despite a recent share price of $92.41, the stock has seen a 34.47% decline over 90 days and a 40.40% drop over the past year. Analysts suggest a fair value of $138.14, indicating potential undervaluation. The company reports strong growth in its Evergreen platform, but risks from regulation and competition remain. Investors are encouraged to assess the balance of opportunity and risk in light of these developments.

Simplywall

Assessing Hamilton Lane (HLNE) Valuation As New Interval Funds And Tokenization Expand Growth Channels

Oppenheimer & Co. Inc. has acquired a new stake in Hamilton Lane Inc. (NASDAQ:HLNE), purchasing 17,332 shares valued at approximately $2.33 million. Other institutional investors have also increased their holdings in Hamilton Lane. Analysts have issued mixed ratings, with Oppenheimer lowering its price target from $230 to $171, while JPMorgan upgraded the stock to 'overweight' with a target of $166. Hamilton Lane's stock is currently trading at $91.12, with a market cap of $5.08 billion and a P/E ratio of 16.36. The company reported strong earnings, exceeding estimates with a revenue increase of 18% year-over-year.

Market Beat

Oppenheimer

UBS Group AG

JPMorgan Chase

JPMORGAN CHASE & CO. 4.20% DEP SHS REPSTG 1/400TH PFD SER MM

JPMORGAN CHASE & CO. 6%NON CUM DEP SHS REP 1/400TH PFD SER EE

JPMORGAN CHASE & CO. DEP REP 1/400TH (5.75% NON CUM PFD DD)

JPMORGAN CHASE & CO. 4.625% DEP SH RE 1/400TH INT NO CU PF LL

JPMorgan Chase & Co.

JPMORGAN CHASE & CO. 4.55% DEP SHS REPSTG 1/400TH PFD SER JJ

JPMORGAN CHASE & CO. 4.75 DEP SHS REP 1/400 NCUM PFD SR GG

Oppenheimer & Co. Inc. Takes Position in Hamilton Lane Inc. $HLNE

MidOcean Announces Successful Close of Single-Asset Continuation Vehicle for Cloyes | HLNE Stock News

StockTitan

MidOcean Announces Successful Close of Single-Asset Continuation Vehicle for Cloyes | HLNE Stock News

Hamilton Lane (HLNE.US)

Hamilton Lane INC Q4 Sales Decline

HAMILTON LANE INCORPORATED REPORTS FOURTH QUARTER AND FISCAL YEAR 2026 RESULTS

Hamilton Lane (HLNE) Q1 Earnings Report Preview: What To Look For

Assessing Hamilton Lane (HLNE) Valuation As New Interval Funds And Tokenization Expand Growth Channels

Oppenheimer & Co. Inc. Takes Position in Hamilton Lane Inc. $HLNE

MidOcean Announces Successful Close of Single-Asset Continuation Vehicle for Cloyes | HLNE Stock News

Trending